If you are having trouble viewing this e-mail click here
European Research Infrastructures
for Poverty Related Diseases
Newsletter June 2014

Dear Partner,

I'm happy to send you the first electronic newsletter of the EURIPRED project (European Research Infrastructures for Poverty Related Diseases). With this letter we want to update our partners, allies and everyone else who's interested in our activities. You receive this newsletter because your e-mail address is known to us, and because we think you might be interested in our activities.

Please don't hesitate to forward this mail to anyone who could also be interested in reading it. If they want to receive their own e-newsletter in the future, they can subscribe on our website. If you're not interested in receiving our newsletter anymore, you can unsubcribe via the unsubscribe button at the end of this newsletter.

I hope you will enjoy reading our news!

Dr Mei Mei Ho, Project Co-ordinator,
National Institute for Biological Standards and Control (NIBSC),
United Kingdom

EURIPRED (European Research Infrastructures for Poverty Related Diseases) is a collaborative infrastructure programme. The overall goal is to coordinate and integrate international resources into a single specialised infrastructure to support European HIV, TB, Malaria and Hepatitis B/ C virus studies from early drug, vaccine and microbicide discovery to clinical trials. The ultimate aim is to speed the development of new tools (vaccines, drugs, microbicides) to combat these poverty related diseases.This will be achieved by creating partnerships between European scientists and international research teams from disease endemic countries and strong collaborations between industry and public sector research. EURIPRED is co-funded with € 8.5 million by the European Commission. Scientists from 17 research partners in 10 countries collaborate in this programme. Read more on our website

The training component of EURIPRED, comprising of workshops and laboratory exchanges is expected to create opportunities for scientists from candidate countries, new member states, and also from the developing countries, to become integrated into our project. Training will take place at several key laboratories, but also includes e-learning modules. Upcoming trainings and video tutorials:

Read more on our website

Through the EURIPRED project there will be a large number of new reagents made available to researchers. These reagents will support research in HIV as well as other Poverty Related Diseases (PRD) and are expected to include matched sets of reagents (proteins, antibodies, clones, peptides and viruses) based on circulating strains for HIV, Malaria, Tuberculosis and Hepatitis B/ C. Reagents produced through the EURIPRED project will be housed in the Centre for AIDS Reagents (CFAR) repository, based at the National Institute for Biological Standards and Control (NIBSC), a centre of the Medicines and Healthcare Products Regulatory Agency,  in the United Kingdom. Established in 1989 the repository has been well supported by the European Commission and provides a lasting legacy for research materials produced through EC funded HIV research projects. Read how to obtain the reagents

Dr Mei Mei Ho, Prinicipal Scientist at the National Institute for Biological Standards and Control (NIBSC), is coordinator of the EURIPRED project. Together with project manager Sarah Gilbert of NIBSC she is responsible for the daily management of the consortium activities and periodically reporting to the EC office. According to Mei the idea behind EURIPRED is to build on the success of the establishment of Centre for AIDS Reagents (CFAR). Her Institute NIBSC took the initiative to extend this important resource to cover the research communities in other poverty related diseases, such as tuberculosis (TB) and malaria.

“Though similar resources for TB or malaria are available, they are scattered,” she said. “The goal of EURIPRED is to create a pan-European infrastructure to support European research in these areas. This integrated approach will strengthen international cooperation among industrial partners, government and the academic communities. It will increase research capacity in the EU and developing countries, minimise fragmentation & duplication of research efforts and pool fragmented resources to improve efficiency and effectiveness. In particular linking biobanks worldwide, is an interesting part of the project.” Read the whole interview on our website

Copyright © 2012 TBVI
To unsubscribe , please click here